Kissei Pharmaceutical Co., Ltd. (TYO:4547)
Japan · Delayed Price · Currency is JPY 3,890.00
+15.00 (0.39%)
May 29, 2026, 3:30 PM JST
Kissei Pharmaceutical Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 28, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 161,248 | 192,752 | 164,586 | 156,266 | 121,792 | 117,826 | |
Market Cap Growth | -0.74% | 17.11% | 5.32% | 28.31% | 3.36% | 4.29% |
Enterprise Value | 109,464 | 148,613 | 122,521 | 115,492 | 77,037 | 78,311 |
Last Close Price | 3890.00 | 4650.00 | 3713.50 | 3324.47 | 2425.93 | 2274.71 |
PE Ratio | 11.73 | 13.99 | 13.76 | 14.00 | 11.57 | 9.12 |
Forward PE | 15.11 | 15.06 | 17.88 | 14.26 | 10.90 | 36.67 |
PS Ratio | 1.66 | 1.98 | 1.86 | 2.07 | 1.81 | 1.80 |
PB Ratio | 0.70 | 0.83 | 0.78 | 0.71 | 0.63 | 0.58 |
P/TBV Ratio | 0.71 | 0.85 | 0.80 | 0.72 | 0.63 | 0.59 |
P/FCF Ratio | - | - | 81.72 | - | - | 2677.87 |
P/OCF Ratio | - | - | 25.24 | - | - | 76.86 |
PEG Ratio | 2.65 | 1.13 | 1.13 | 1.13 | 1.13 | 1.13 |
EV/Sales Ratio | 1.12 | 1.53 | 1.39 | 1.53 | 1.14 | 1.20 |
EV/EBITDA Ratio | 63.72 | 86.50 | 11.79 | 13.96 | 25.97 | 33.64 |
EV/EBIT Ratio | - | - | 21.22 | 28.75 | - | - |
EV/FCF Ratio | -17.19 | - | 60.83 | - | - | 1779.80 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Debt / EBITDA Ratio | 0.73 | 0.73 | 0.12 | 0.16 | 0.50 | 0.70 |
Debt / FCF Ratio | - | - | 0.64 | - | - | 37.27 |
Net Debt / Equity Ratio | -0.23 | -0.23 | -0.22 | -0.20 | -0.25 | -0.25 |
Net Debt / EBITDA Ratio | -30.95 | -30.95 | -4.56 | -5.39 | -16.22 | -22.13 |
Net Debt / FCF Ratio | 8.35 | 8.35 | -23.52 | 15.49 | 5.48 | -1170.73 |
Asset Turnover | 0.38 | 0.38 | 0.35 | 0.31 | 0.29 | 0.26 |
Inventory Turnover | 2.04 | 2.04 | 1.73 | 1.56 | 1.68 | 1.75 |
Quick Ratio | 3.97 | 3.97 | 4.68 | 4.17 | 4.79 | 4.01 |
Current Ratio | 5.30 | 5.30 | 6.45 | 5.92 | 6.73 | 5.30 |
Return on Equity (ROE) | 6.32% | 6.32% | 5.55% | 5.43% | 5.36% | 6.17% |
Return on Assets (ROA) | -0.70% | -0.70% | 1.43% | 1.04% | -0.31% | -0.35% |
Return on Invested Capital (ROIC) | -1.38% | -1.42% | 2.61% | 1.94% | -0.60% | -0.68% |
Return on Capital Employed (ROCE) | -1.20% | -1.20% | 2.50% | 1.70% | -0.60% | -0.60% |
Earnings Yield | 8.55% | 7.15% | 7.27% | 7.14% | 8.64% | 10.97% |
FCF Yield | -3.95% | -3.30% | 1.22% | -1.84% | -7.21% | 0.04% |
Dividend Yield | 3.34% | 2.58% | 2.69% | 2.47% | 3.30% | 2.46% |
Payout Ratio | 35.13% | 35.13% | 31.78% | 33.35% | 29.78% | 19.63% |
Buyback Yield / Dilution | 4.72% | 4.72% | 3.62% | 1.86% | - | 1.18% |
Total Shareholder Return | 8.06% | 7.30% | 6.31% | 4.32% | 3.30% | 3.64% |